Durvalumab after chemoradiotherapy is currently the most promising treatment for stage III NSCLC. View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2019-04-04

AUTHORS

Martin Wilhelm

ABSTRACT

N/A

Journal

TITLE

Strahlentherapie und Onkologie

ISSUE

N/A

VOLUME

N/A

Author Affiliations

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s00066-019-01456-3

DOI

http://dx.doi.org/10.1007/s00066-019-01456-3

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1113185135

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/30949719


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "author": [
      {
        "affiliation": {
          "alternateName": "Nuremberg Hospital", 
          "id": "https://www.grid.ac/institutes/grid.419835.2", 
          "name": [
            "Universit\u00e4tsklinik f\u00fcr Innere Medizin 5, Klinikum N\u00fcrnberg, Paracelsus Medizinische Privatuniversit\u00e4t, Prof.-Ernst-Nathan-Str.\u00a01, 90419, N\u00fcrnberg, Deutschland. Martin.Wilhelm@klinikum-nuernberg.de."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Wilhelm", 
        "givenName": "Martin", 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1016/s1470-2045(13)70510-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003864299"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1470-2045(14)71207-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035529456"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1172/jci67313", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044317762"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.5306/wjco.v8.i1.1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1083797451"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa1709937", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1091511599"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa1809697", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1107228713"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa1809697", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1107228713"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2019-04-04", 
    "datePublishedReg": "2019-04-04", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s00066-019-01456-3", 
    "inLanguage": [
      "de"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1054450", 
        "issn": [
          "0179-7158", 
          "1439-099X"
        ], 
        "name": "Strahlentherapie und Onkologie", 
        "type": "Periodical"
      }
    ], 
    "name": "Durvalumab after chemoradiotherapy is currently the most promising treatment for stage\u00a0III NSCLC.", 
    "productId": [
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "30949719"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "8603469"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00066-019-01456-3"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1113185135"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00066-019-01456-3", 
      "https://app.dimensions.ai/details/publication/pub.1113185135"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T14:17", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000372_0000000372/records_117097_00000003.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1007/s00066-019-01456-3"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00066-019-01456-3'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00066-019-01456-3'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00066-019-01456-3'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00066-019-01456-3'


 

This table displays all metadata directly associated to this object as RDF triples.

66 TRIPLES      18 PREDICATES      27 URIs      15 LITERALS      6 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s00066-019-01456-3 schema:author N82ed419ede29491a9be1081dca390f75
2 schema:citation https://doi.org/10.1016/s1470-2045(13)70510-2
3 https://doi.org/10.1016/s1470-2045(14)71207-0
4 https://doi.org/10.1056/nejmoa1709937
5 https://doi.org/10.1056/nejmoa1809697
6 https://doi.org/10.1172/jci67313
7 https://doi.org/10.5306/wjco.v8.i1.1
8 schema:datePublished 2019-04-04
9 schema:datePublishedReg 2019-04-04
10 schema:genre research_article
11 schema:inLanguage de
12 schema:isAccessibleForFree false
13 schema:isPartOf sg:journal.1054450
14 schema:name Durvalumab after chemoradiotherapy is currently the most promising treatment for stage III NSCLC.
15 schema:productId N472a5f6c9184498eab611b666ae91efa
16 N73b76fe6dac64182aee1190a355401d3
17 Nc8831b8316404e19ab35f5e124a41e37
18 Ne0b29a1ee241467d98b9ab33911d3cd9
19 schema:sameAs https://app.dimensions.ai/details/publication/pub.1113185135
20 https://doi.org/10.1007/s00066-019-01456-3
21 schema:sdDatePublished 2019-04-11T14:17
22 schema:sdLicense https://scigraph.springernature.com/explorer/license/
23 schema:sdPublisher N44221504b706462899a1a4c5c7a53cf7
24 schema:url http://link.springer.com/10.1007/s00066-019-01456-3
25 sgo:license sg:explorer/license/
26 sgo:sdDataset articles
27 rdf:type schema:ScholarlyArticle
28 N44221504b706462899a1a4c5c7a53cf7 schema:name Springer Nature - SN SciGraph project
29 rdf:type schema:Organization
30 N472a5f6c9184498eab611b666ae91efa schema:name dimensions_id
31 schema:value pub.1113185135
32 rdf:type schema:PropertyValue
33 N73b76fe6dac64182aee1190a355401d3 schema:name pubmed_id
34 schema:value 30949719
35 rdf:type schema:PropertyValue
36 N7fc98488dbe14a3f953fab26c397b343 schema:affiliation https://www.grid.ac/institutes/grid.419835.2
37 schema:familyName Wilhelm
38 schema:givenName Martin
39 rdf:type schema:Person
40 N82ed419ede29491a9be1081dca390f75 rdf:first N7fc98488dbe14a3f953fab26c397b343
41 rdf:rest rdf:nil
42 Nc8831b8316404e19ab35f5e124a41e37 schema:name doi
43 schema:value 10.1007/s00066-019-01456-3
44 rdf:type schema:PropertyValue
45 Ne0b29a1ee241467d98b9ab33911d3cd9 schema:name nlm_unique_id
46 schema:value 8603469
47 rdf:type schema:PropertyValue
48 sg:journal.1054450 schema:issn 0179-7158
49 1439-099X
50 schema:name Strahlentherapie und Onkologie
51 rdf:type schema:Periodical
52 https://doi.org/10.1016/s1470-2045(13)70510-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003864299
53 rdf:type schema:CreativeWork
54 https://doi.org/10.1016/s1470-2045(14)71207-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035529456
55 rdf:type schema:CreativeWork
56 https://doi.org/10.1056/nejmoa1709937 schema:sameAs https://app.dimensions.ai/details/publication/pub.1091511599
57 rdf:type schema:CreativeWork
58 https://doi.org/10.1056/nejmoa1809697 schema:sameAs https://app.dimensions.ai/details/publication/pub.1107228713
59 rdf:type schema:CreativeWork
60 https://doi.org/10.1172/jci67313 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044317762
61 rdf:type schema:CreativeWork
62 https://doi.org/10.5306/wjco.v8.i1.1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1083797451
63 rdf:type schema:CreativeWork
64 https://www.grid.ac/institutes/grid.419835.2 schema:alternateName Nuremberg Hospital
65 schema:name Universitätsklinik für Innere Medizin 5, Klinikum Nürnberg, Paracelsus Medizinische Privatuniversität, Prof.-Ernst-Nathan-Str. 1, 90419, Nürnberg, Deutschland. Martin.Wilhelm@klinikum-nuernberg.de.
66 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...